Search Results

Prevalence of Insomnia (Symptoms) in T2D and Association With Metabolic Parameters and Glycemic Control: Meta-Analysis.

• Authors : Koopman ADM; Amsterdam UMC, location VUmc, Department of Epidemiology and Biostatistics, Amsterdam Public Health Research Institute, HV Amsterdam, the Netherlands.; Beulens JW

Subjects: Insulin Resistance*; Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*physiopathology

• Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2020 Mar 01; Vol. 105 (3).Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Agricola

Record details

Bone Turnover Markers in Men and Women with Impaired Fasting Glucose and Diabetes.

• Authors : Holloway-Kew KL; Deakin University, Geelong, Australia. .; De Abreu LLF

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Bone Remodeling/Bone Remodeling/Bone Remodeling/*physiology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood

• Source: Calcified tissue international [Calcif Tissue Int] 2019 Jun; Vol. 104 (6), pp. 599-604. Date of Electronic Publication: 2019 Jan 24.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Identification of Novel Circulating Biomarkers Predicting Rapid Decline in Renal Function in Type 2 Diabetes: The Fremantle Diabetes Study Phase II.

• Authors : Peters KE; Medical School, Faculty of Health and Medical Sciences, The University of Western Australia, Fremantle, Western Australia, Australia.; Proteomics International, Perth, Western Australia, Australia.

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*blood ; Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/Renal Insufficiency, Chronic/*blood

• Source: Diabetes care [Diabetes Care] 2017 Nov; Vol. 40 (11), pp. 1548-1555. Date of Electronic Publication: 2017 Aug 29.Publisher: American Diabetes Association Country of Publication: United States NLM ID: 7805975 Publication Model: Print-Electronic Cited Medium:

Record details

Glucose effectiveness in nondiabetic relatives: dysglycemia and β-cell function at 10 years.

• Authors : Egede MB; Diabetes Research Centre (M.B.E., J.-E.H., T.T.D., K.L., H.B.-N.), Department of Endocrinology, University Hospital of Southern Denmark, DK-5000 Odense, Denmark; The Bio21 Molecular Science and Biotechnology Institute (C.R.), University of Melbourne, Parkville 3052, Victoria, Australia, and Departments of Endocrinology and Diabetes, and Medicine (G.W., F.P.A.), St Vincent's Hospital, Fitzroy 3065, Victoria, Australia.

Subjects: Diabetes Mellitus, Type 2*; Blood Glucose/Blood Glucose/Blood Glucose/*metabolism ; Glucose Intolerance/Glucose Intolerance/Glucose Intolerance/*epidemiology

• Source: The Journal of clinical endocrinology and metabolism [J Clin Endocrinol Metab] 2014 Apr; Vol. 99 (4), pp. 1420-4. Date of Electronic Publication: 2014 Jan 16.Publisher: Oxford University Press Country of Publication: United States NLM ID: 0375362 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Obesity is associated with activated and insulin resistant immune cells.

• Authors : Viardot A; Diabetes and Obesity Research Program, Garvan Institute of Medical Research, Sydney-Darlinghurst, NSW 2010, Australia. ; Heilbronn LK

Subjects: Insulin Resistance*; Biomarkers/Biomarkers/Biomarkers/*metabolism ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*etiology

• Source: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2012 Jul; Vol. 28 (5), pp. 447-54. Date of Electronic Publication: 2012 Apr 10.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883450 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes.

• Authors : Natale P; Sydney School of Public Health, The University of Sydney, Sydney, Australia.; Nephrology, Dialysis and Transplantation Unit, Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/Renal Insufficiency, Chronic*/complications

• Source: The Cochrane database of systematic reviews [Cochrane Database Syst Rev] 2024 May 21; Vol. 5. Cochrane AN: CD015588. Date of Electronic Publication: 2024 May 21.Publisher: Wiley Country of Publication: England NLM ID: 100909747 Publication Model: Electronic Cited Medium: Internet ISSN: 1469-493X

Record details

Vascular endothelial growth factors and risk of cardio-renal events: Results from the CREDENCE trial.

• Authors : Januzzi JL Jr; Cardiology Division, Massachusetts General Hospital and Harvard Medical School, Boston, MA; Heart Failure and Biomarker Trials, Baim Institute for Clinical Research, Boston, MA. Electronic address: .

Subjects: Biomarkers*/Biomarkers*/Biomarkers*/blood ; Canagliflozin*/Canagliflozin*/Canagliflozin*/therapeutic use ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/blood

• Source: American heart journal [Am Heart J] 2024 May; Vol. 271, pp. 38-47. Date of Electronic Publication: 2024 Feb 22.Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744

Record details

Effects of Dapagliflozin in Chronic Kidney Disease Across the Spectrum of Age and by Sex.

• Authors : Yu MK; Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.; Vart P

Subjects: Glucosides*/Glucosides*/Glucosides*/therapeutic use ; Glucosides*/Glucosides*/Glucosides*/adverse effects ; Benzhydryl Compounds*/Benzhydryl Compounds*/Benzhydryl Compounds*/therapeutic use

• Source: Journal of general internal medicine [J Gen Intern Med] 2024 May; Vol. 39 (6), pp. 921-930. Date of Electronic Publication: 2023 Dec 14.Publisher: Springer Country of Publication: United States NLM ID: 8605834 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Circulating metabolomic markers linking diabetic kidney disease and incident cardiovascular disease in type 2 diabetes: analyses from the Hong Kong Diabetes Biobank.

• Authors : Jin Q; Lau ESH ...

Subjects: Diabetic Nephropathies*/Diabetic Nephropathies*/Diabetic Nephropathies*/metabolism ; Diabetes Mellitus, Type 2* ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/complications

• Source: Diabetologia [Diabetologia] 2024 May; Vol. 67 (5), pp. 837-849. Date of Electronic Publication: 2024 Feb 27.Publisher: Springer Verlag Country of Publication: Germany NLM ID: 0006777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details